Literature DB >> 12587789

Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri.

E Kirches1, C Mawrin, R Schneider-Stock, G Krause, C Scherlach, K Dietzmann.   

Abstract

The aim of this study was a clonal analysis of gliomatosis cerebri (GC), a rare disease characterized by diffuse, extensively infiltrating glial tumors of the central nervous system. Two females of the series were not informative in assays for X-chromosomal inactivation, and a polycytosine tract of the mitochondrial DNA (mtDNA) was tested as a clonal marker. Following fluorescent PCR, a fraction of human individuals shows several electrophoretic bands in normal tissues, some of which can be lost in corresponding glial tumors. Two male patients of our series fulfilled this prerequisite and were thus informative. In patient 1, four tumor samples from the left temporal and occipital cortex, histologically corresponding to WHO grades III and IV, showed an identical loss of bands, which was not observed in tumor-free brain and in tumors from the left cerebellum, from fornix and corpus callosum, and from the right occipital cortex, corresponding to WHO grades III and IV. Since this patient exhibited a TP53 mutation in exon 7, we sequenced this exon in all tissue samples of this individual. The mutation was found selectively in the tumor samples with a loss of mtDNA bands. In patient 2, all tumors (histologically corresponding to WHO grade II) from putamen, thalamus, midbrain and right parietal cortex exhibited an identical loss of bands in the mtDNA analysis. Taken together, these results support that even distant tumors in a patient with GC can share a common clonal origin. They demonstrate the extraordinary mobility and infiltrative power of these tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587789     DOI: 10.1023/a:1021296212233

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  9 in total

1.  Heterogeneous tissue distribution of a mitochondrial DNA polymorphism in heteroplasmic subjects without mitochondrial disorders.

Authors:  E Kirches; M Michael; M Warich-Kirches; T Schneider; S Weis; G Krause; C Mawrin; K Dietzmann
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

2.  Clonal analysis of gliomas.

Authors:  M M Kattar; W J Kupsky; R K Shimoyama; T D Vo; M W Olson; G R Bargar; F H Sarkar
Journal:  Hum Pathol       Date:  1997-10       Impact factor: 3.466

3.  Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.

Authors:  C Mawrin; V Aumann; E Kirches; R Schneider-Stock; C Scherlach; S Vogel; U Mittler; K Dietzmann; G Krause; S Weis
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

4.  Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA.

Authors:  E E Jazin; L Cavelier; I Eriksson; L Oreland; U Gyllensten
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: support for a genetic bottleneck.

Authors:  D R Marchington; G M Hartshorne; D Barlow; J Poulton
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors.

Authors:  E Kirches; M Michael; C Woy; T Schneider; M Warich-Kirches; R Schneider-Stock; K Winkler; H Wittig; K Dietzmann
Journal:  Genes Chromosomes Cancer       Date:  1999-09       Impact factor: 5.006

8.  Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.

Authors:  M Sanchez-Cespedes; P Parrella; S Nomoto; D Cohen; Y Xiao; M Esteller; C Jeronimo; R C Jordan; T Nicol; W M Koch; M Schoenberg; P Mazzarelli; V M Fazio; D Sidransky
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

9.  Chromosomes in gliomatosis cerebri.

Authors:  B K Hecht; C Turc-Carel; M Chatel; M Lonjon; J L Roche; J Gioanni; F Hecht; P Gaudray
Journal:  Genes Chromosomes Cancer       Date:  1995-10       Impact factor: 5.006

  9 in total
  6 in total

1.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri.

Authors:  Hye Sook Min; Bomi Kim; Sung-Hye Park
Journal:  J Neurooncol       Date:  2008-08-13       Impact factor: 4.130

Review 3.  MtDNA As a Cancer Marker: A Finally Closed Chapter?

Authors:  Elmar Kirches
Journal:  Curr Genomics       Date:  2017-06       Impact factor: 2.236

4.  Mitochondrial and nuclear genes of mitochondrial components in cancer.

Authors:  E Kirches
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

5.  Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors.

Authors:  Michael A Kiebish; Thomas N Seyfried
Journal:  BMC Cancer       Date:  2005-08-16       Impact factor: 4.430

6.  Clinical implications and utility of field cancerization.

Authors:  Gabriel D Dakubo; John P Jakupciak; Mark A Birch-Machin; Ryan L Parr
Journal:  Cancer Cell Int       Date:  2007-03-15       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.